News & Events
News:
January 31, 2024: Life Sciences company Orexa raises investments of € 870,000.
January 19, 2024: Orexa announces first patient dosed in Phase 2 Trial in post-operative patients.
June 19, 2023: Orexa collaborates with CRO QPS for Phase 2a Trial in the Prevention of Post-Operative Ileus.
January 10, 2023: Life Sciences company Orexa raises investments of € 485,000.
August 31, 2022: Life Sciences company Orexa completes financing round of € 1.2 million.
March 1st, 2022: Orexa announces the successful completion of a local financing round of € 800,000.
Events:
We have participated at the following events:
BIO Europe Spring, Barcelona: 18-20 March 2024
ChinaBio Partnering Forum: 10-11 November 2022
BIO Europe Digital: 25-28 October 2021
Developing a medicine that increases food intake.
